Mental Health Book

Anxiety Disorders

Bipolar Disorder

Chemical Dependency

Depression

Psychosis

Sleep Disorders

Sexual Development

Obstetrics Chapter related topics

//fpnotebook.com/

Haloperidol

Aka: Haloperidol, Haldol, Haloperidol Lactate, Haloperidol decanoate
  1. See Also
    1. Antipsychotic Medication
    2. Psychosis
  2. Indications
    1. Psychosis
    2. Delirium
    3. Schizophrenia
    4. Tic Disorders (including Tourette's Syndrome)
    5. Acute Mania
  3. Contraindications
    1. Pregnancy and Lactation
    2. Phencyclidine (PCP) Overdose
    3. Anticholinergic Syndromes
    4. Alcohol or Benzodiazepine Withdrawal
    5. Hepatic Insufficiency
    6. Neuroleptic Malignant Syndrome
  4. Class
    1. First Generation Antipsychotic
  5. Dosing: Haloperidol
    1. Dose
      1. Adult: 5-10 mg PO, IM, or IV
      2. Peds: 0.5-1 mg PO, IM or IV
      3. Adolescent: 1-5 mg PO, IM or IV
      4. Elderly: 0.5-2 mg PO, IM or IV
    2. Intervals: Scheduled and repeated dosing intervals
      1. May repeat every 30-60 minutes
      2. Maximum: 300 mg/24 hours (avoid cummulative dose over 100 mg in 24 hours)
      3. May dose regularly every 6-8 hours
        1. Typical effective dose: 5 mg PO, IV, or IM tid (lower doses in the elderly)
      4. Total dose >3 mg/day is associated with Extrapyramidal Side Effects
  6. Dosing: Haloperidol decanoate (depot form)
    1. Haloperidol decanoate 100 mg IM every 4 weeks
    2. Cost effective (may be as low as $19 generic)
  7. Precautions
    1. Intravenous doses have a much shorter duration of action than other routes
    2. Antipsychotics are associated with increased mortality in the elderly
  8. Adverse effects
    1. Serious
      1. See Extrapyramidal Side Effects (EPSE)
      2. Neuroleptic Malignant Syndrome
      3. Hypotension
      4. Dystonia
      5. Seizures
      6. Prolonged QT interval
        1. Risk of Torsades de Pointes
        2. Dose related effect with higher risk at higher doses
    2. Common
      1. Insomnia
      2. Restlessness
      3. Anxiety
      4. Sedation
      5. Headache
      6. Weight gain
      7. Hyperprolactinemia
      8. Blood dyscrasia
  9. Monitoring
    1. Serum Prolactin
      1. Obtain if indicated
    2. Complete Blood Count (indicated if history of Leukopenia)
      1. Baseline
      2. Monthly in first 3 months of therapy
Medication Costs
Haloperidol (on 6/18/2017 at Walmart.com)
Haloperidol 0.5mg #30 tablets for $4.00 $0.13 each
Haloperidol 0.5mg #90 tablets for $10.00 $0.11 each
Haloperidol 1mg #30 tablets for $4.00 $0.13 each
Haloperidol 1mg #90 tablets for $10.00 $0.11 each
Haloperidol 2mg #30 tablets for $4.00 $0.13 each
Haloperidol 2mg #90 tablets for $10.00 $0.11 each
Haloperidol 5mg #30 tablets for $4.00 $0.13 each
Haloperidol 5mg #90 tablets for $10.00 $0.11 each
haloperidol (on 5/17/2017 at Medicaid.Gov Pharmacy Drug pricing)
HALOPERIDOL 0.5 MG TABLET Generic $0.22 each
HALOPERIDOL 1 MG TABLET Generic $0.27 each
HALOPERIDOL 10 MG TABLET Generic $0.57 each
HALOPERIDOL 2 MG TABLET Generic $0.35 each
HALOPERIDOL 20 MG TABLET Generic $1.38 each
HALOPERIDOL 5 MG TABLET Generic $0.45 each
HALOPERIDOL LAC 2 MG/ML CONC Generic $0.06 per ml
HALOPERIDOL LAC 5 MG/ML VIAL Generic $0.79 per ml
FPNotebook does not benefit financially from showing this medication data or their pharmacy links. This information is provided only to help medical providers and their patients see relative costs. Insurance plans negotiate lower medication prices with suppliers. Prices shown here are out of pocket, non-negotiated rates. See Needy Meds for financial assistance information.

Haloperidol (C0018546)

Definition (MSH) A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
Definition (NCI_NCI-GLOSS) A drug used to treat certain mental and neurological disorders. It is also being studied in the treatment of nausea and vomiting caused by some cancer treatments. It is a type of antiemetic and a type of antipsychotic.
Definition (NCI) A phenylbutylpiperadine derivative with antipsychotic, neuroleptic, and antiemetic activities. Haloperidol competitively blocks postsynaptic dopamine (D2) receptors in the mesolimbic system of the brain, thereby eliminating dopamine neurotransmission and leading to antidelusionary and antihallucinagenic effects. Antagonistic activity mediated through D2 dopamine receptors in the chemoreceptive trigger zone (CTZ) accounts for its antiemetic activity.
Definition (CSP) USP lists as an antipsychotic and as an "antidyskinetic" used in Tourette syndrome.
Definition (PDQ) A phenylbutylpiperadine derivative with antipsychotic, neuroleptic and antiemetic effects. Haloperidol competitively blocks postsynaptic dopamine (D2) receptors in the mesolimbic system of the brain, thereby eliminating dopamine neurotransmission and leading to antidelusionary and antihallucinagenic effects. The antagonistic activity mediated through D2 dopamine receptors in the chemoreceptive trigger zone (CTZ) accounts for its antiemetic activity. Check for "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=39474&idtype=1" active clinical trials or "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=39474&idtype=1&closed=1" closed clinical trials using this agent. ("http://nciterms.nci.nih.gov:80/NCIBrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C537" NCI Thesaurus)
Concepts Pharmacologic Substance (T121) , Organic Chemical (T109)
MSH D006220
SnomedCT 321415008, 323259009, 10756001, 386837002
LNC LP16158-5, MTHU005005
English Haloperidol, 1-Butanone, 4-(4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-, Haloperidol [antipsychotic], Haloperidol [tics, chorea], Haloperidol [tics, chorea] [see D47..], 4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl)-1-butanone, HALOPERIDOL, haloperidol (medication), Haloperidol [Chemical/Ingredient], Haloperidol [tics, chorea] [see D47..] (product), Haloperidol [antipsychotic] (product), haloperidol, Haloperidol (product), Haloperidol (substance), Haloperidol [antipsychotic] (substance), Haloperidol [tics, chorea] [see D47..] (substance)
Swedish Haloperidol
Czech haloperidol
Finnish Haloperidoli
Russian GALOPERIDOL, ГАЛОПЕРИДОЛ
Japanese ハロペリドール
Croatian HALOPERIDOL
Polish Haloperidol
Spanish haloperidol [tics, corea] [véase D47..] (producto), haloperidol [antipsicótico], haloperidol [tics, corea] [véase D47..], haloperidol [antipsicótico] (producto), haloperidol (producto), haloperidol (sustancia), haloperidol, Haloperidol
French Halopéridol
German Haloperidol
Italian Aloperidolo
Portuguese Haloperidol
Sources
Derived from the NIH UMLS (Unified Medical Language System)


haloperidol decanoate (C0062103)

Definition (NCI) The decanoate ester of haloperidol, a phenylbutylpiperadine derivative with antipsychotic, neuroleptic and antiemetic effects. Haloperidol competitively blocks postsynaptic dopamine (D2) receptors in the mesolimbic system of the brain leading to anti-delusionary and anti-hallucinogenic effects. The antagonistic activity mediated through D2 dopamine receptors in the chemoreceptive trigger zone (CTZ) account for its antiemetic activity.
Concepts Pharmacologic Substance (T121) , Organic Chemical (T109)
MSH C033563
SnomedCT 412196004, 321699007
English haloperidol decanoate, Haloperidol Decanoate, Haloperidol deconoate, haloperidol decanoate (discontinued) (medication), haloperidol decanoate (discontinued), haloperidol decanoate [Chemical/Ingredient], HALOPERIDOL DECANOATE, Haloperidol decanoate, Haloperidol decanoate (product), Haloperidol decanoate (substance), Haloperidol deconoate (substance)
Spanish decanoato de haloperidol (producto), decanoato de haloperidol, decanoato de haloperidol (sustancia)
Sources
Derived from the NIH UMLS (Unified Medical Language System)


Haldol (C0591585)

Concepts Pharmacologic Substance (T121) , Organic Chemical (T109)
MSH D006220
English Haldol, haldol
Sources
Derived from the NIH UMLS (Unified Medical Language System)


Haloperidol lactate (C0720809)

Concepts Pharmacologic Substance (T121) , Organic Chemical (T109)
SnomedCT 412197008
English haloperidol lactate, haloperidol lactate (medication), Haloperidol lactate, HALOPERIDOL LACTATE, Haloperidol Lactate, Haloperidol lactate (substance)
Spanish lactato de haloperidol (sustancia), lactato de haloperidol
Sources
Derived from the NIH UMLS (Unified Medical Language System)


You are currently viewing the original 'fpnotebook.com\legacy' version of this website. Internet Explorer 8.0 and older will automatically be redirected to this legacy version.

If you are using a modern web browser, you may instead navigate to the newer desktop version of fpnotebook. Another, mobile version is also available which should function on both newer and older web browsers.

Please Contact Me as you run across problems with any of these versions on the website.

Navigation Tree